These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32006198)

  • 1. DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation.
    Yang Z; Zhu H; Zhang L; Wei Q; Zhou L; Xu X; Song P; Liu J; Xie H; Zheng S
    Mol Biol Rep; 2020 Mar; 47(3):1773-1782. PubMed ID: 32006198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.
    Wu LM; Zhang F; Zhou L; Yang Z; Xie HY; Zheng SS
    BMC Cancer; 2010 Aug; 10():399. PubMed ID: 20678188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
    Liu M; Cui LH; Li CC; Zhang L
    Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients.
    Jiang BG; Wang N; Huang J; Yang Y; Sun LL; Pan ZY; Zhou WP
    Oncotarget; 2017 Apr; 8(17):28621-28627. PubMed ID: 28404963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience.
    Wehrle CJ; Raj R; Maspero M; Satish S; Eghtesad B; Pita A; Kim J; Khalil M; Calderon E; Orabi D; Zervos B; Modaresi Esfeh J; Whitsett Linganna M; Diago-Uso T; Fujiki M; Quintini C; Kwon CD; Miller C; Pinna A; Aucejo F; Hashimoto K; Schlegel A
    Int J Surg; 2024 May; 110(5):2818-2831. PubMed ID: 38241354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation site
    Yang Z; Chen W; Zhu H; Zhang L; Zhou K; Tang H; Sun R; Huang Y; Xie H; Zheng S; Jia C
    Future Oncol; 2022 Jun; 18(19):2401-2413. PubMed ID: 35502765
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
    Sasi W; Jiang WG; Sharma A; Mokbel K
    BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients.
    Saelee P; Chuensumran U; Wongkham S; Chariyalertsak S; Tiwawech D; Petmitr S
    Asian Pac J Cancer Prev; 2012; 13(7):3489-93. PubMed ID: 22994783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
    Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
    Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
    Qiu X; Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Mol Cell Biochem; 2013 Jun; 378(1-2):99-106. PubMed ID: 23475171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.
    Wei L; Huang Y; Zhao R; Zhang J; Liu Q; Liang W; Ding X; Gao B; Li B; Sun C; He J; Yu X; Liu Z; Sun A; Qin Y
    Clin Exp Med; 2018 Feb; 18(1):79-87. PubMed ID: 28951980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
    Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
    Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.
    Zhang X; Wang J; Cheng J; Ding S; Li M; Sun S; Zhang L; Liu S; Chen X; Zhuang H; Lu F
    J Viral Hepat; 2014 Apr; 21(4):264-71. PubMed ID: 23941364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation profiling of SOCS1, SOCS2, SOCS3, CISH and SHP1 in Philadelphia-negative myeloproliferative neoplasm.
    Zhang MY; Fung TK; Chen FY; Chim CS
    J Cell Mol Med; 2013 Oct; 17(10):1282-90. PubMed ID: 24131863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.
    Zhang X; You Q; Zhang X; Chen X
    Int J Mol Sci; 2015 Sep; 16(9):22662-75. PubMed ID: 26393582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
    Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
    J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.